Keyphrases
Proteomics
100%
Phosphoproteomics
100%
Melanoma Cells
100%
ERK2
100%
BRAF Inhibitor (BRAFi)
100%
Inhibitor Resistant
100%
ERK1
57%
Melanoma
28%
Drug Addiction
28%
Acquired Resistance
28%
Cancer Treatment
14%
Molecular Mechanism
14%
Cell Division
14%
In Cancer
14%
Kinase Activity
14%
Transcription Factor
14%
Cell Death
14%
Therapeutic Strategies
14%
Therapeutic Agents
14%
Mass Spectrometry Analysis
14%
Vulnerability
14%
Clinical Efficacy
14%
Cas9 Protein
14%
Control Cell
14%
Glycogen Synthase Kinase 3 (GSK3)
14%
Multidrug-resistant
14%
Possible Mechanisms
14%
Proteomic Response
14%
Phosphoproteomic Analysis
14%
Drug Dependence
14%
Melanoma Treatment
14%
MAPK Inhibitors
14%
Drug Withdrawal
14%
Phenotypic Switching
14%
Proteomic Approach
14%
Molecular Understanding
14%
Biochemistry, Genetics and Molecular Biology
Phosphoproteomics
100%
JUNB
100%
Proteomics
100%
CRISPR/Cas9
33%
Mass Spectrometry
33%
Proteome
33%
Cell Division
33%
Transcription Factors
33%
Kinase
33%
Phosphotransferase
33%
Mitogen-Activated Protein Kinase
33%
Cell Death
33%
Drug Withdrawal
33%
Phosphoproteome
33%